Searchable abstracts of presentations at key conferences in endocrinology

ea0034ye1.5 | Establishing successful collaborations | SFEBES2014

Peer-to-peer collaborations: importance of YE groups

Chapman Karen

The value of mentoring by an experienced, usually older colleague, is widely acknowledged, but just as important is the value of sharing experiences, knowledge and support within a peer group. Peer-to-peer collaboration, or peer mentoring, provides opportunities for networking, friendship, education and career development and advice. Formal groupings and networks often exist locally in the form of student or postdoc societies. The Young Endocrinologists of the Society for Endo...

ea0077p136 | Adrenal and Cardiovascular | SFEBES2021

Glucocorticoid receptor activation regulates cardiomyocyte cell cycle in neonates

Ivy Jessica , Urquijo Helena , Mort Richard , Chapman Karen

In neonates, cardiomyocytes exit the cell cycle thus establishing cardiomyocyte number for life. Further growth is through hypertrophy. Factors that advance the timing of the switch from hyperplastic to hypertrophic growth may increase risk of cardiac disease in adulthood. Early life administration of glucocorticoids is known to increase risk of cardiovascular disease. We hypothesized that dexamethasone, a synthetic glucocorticoid, causes precocious cell cycle exit of neonatal...

ea0050p208 | Diabetes and Cardiovascular | SFEBES2017

Do glucocorticoids cause mitochondrial substrate switching in fetal cardiomyocytes?

Ivy Jessica , Batchen Emma , Carter Roderick , Morton Nicholas , Chapman Karen

Background: During fetal development, the heart switches substrate preference from glucose to fatty acids, such that in the adult heart, 50–70% of ATP is derived from fatty acid oxidation. What triggers this switch is currently unclear. In vivo, the late gestation rise in glucocorticoid levels is essential for structural and functional maturation of the fetal heart. Glucocorticoid treatment of fetal cardiomyocytes induces express...

ea0050p208 | Diabetes and Cardiovascular | SFEBES2017

Do glucocorticoids cause mitochondrial substrate switching in fetal cardiomyocytes?

Ivy Jessica , Batchen Emma , Carter Roderick , Morton Nicholas , Chapman Karen

Background: During fetal development, the heart switches substrate preference from glucose to fatty acids, such that in the adult heart, 50–70% of ATP is derived from fatty acid oxidation. What triggers this switch is currently unclear. In vivo, the late gestation rise in glucocorticoid levels is essential for structural and functional maturation of the fetal heart. Glucocorticoid treatment of fetal cardiomyocytes induces express...

ea0059p100 | Diabetes & cardiovascular | SFEBES2018

Glucocorticoid receptor deficiency alters cardiomyocyte DNA replication in neonatal mice

Petursdottir Megan , Brain Eleanor , Buckley Charlotte , Chapman Karen , Ivy Jessica

During early life, the majority of cardiomyocytes exit the cell cycle and undergo terminal differentiation, becoming binucleated. This establishes the number of cardiomyocytes for the remainder of the lifetime, with subsequent consequences for cardiac resilience in adulthood. Activation of the glucocorticoid receptor (GR) is important for heart maturation: fetal mice lacking GR in cardiomyocytes (SMGRKO) show structural and functional cardiac immaturity. Young adult male and f...

ea0038p196 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Evidence for 11β-HSD1 regulation of brain energy metabolism following systemic inflammation

Verma Manu , Kipari Tiina , Seckl Jonathan , Holmes Megan , Chapman Karen

Background: Chronically elevated brain glucocorticoid (GC) levels impair cognition. In rodents, raised GC levels prior to lipopolyaccharide (LPS) administration potentiate neuroinflammation although GC suppresses neuroinflammation if administered after LPS. 11β-hydroxysteroid dehydrogenase-1 (11β-HSD1) activity can increase intracellular GC levels, including in the brain, without alteration in circulating levels. 11β-HSD1 deficiency/inhibition protects against a...

ea0028p136 | Growth and development | SFEBES2012

Maturational effects of glucocorticoids on fetal cardiomyocytes are direct and mediated by glucocorticoid receptor

Rog-Zielinska Eva , Kenyon Chris , Holmes Megan , Chapman Karen

In addition to their essential role in fetal lung development, glucocorticoids promote late-gestation maturation of the fetal heart as shown by severe functional impairment, structural disorganisation and transcriptome immaturity in fetal hearts of glucocorticoid receptor-deficient (GR-/-) mice. Here we use primary fetal mouse cardiomyocytes (E16-E17.5) to investigate whether these effects of glucocorticoids result from direct actions of GR and whether they are independent of ...

ea0015p138 | Diabetes, metabolism and cardiovascular | SFEBES2008

Differential changes in C/EBP isoforms may underpin tissue-specific dysregulation of 11β-HSD1 with high fat feeding

Esteves Cristina , Morton Nicholas , Seckl Jonathan , Chapman Karen

The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), regenerates active glucocorticoids (cortisol, corticosterone) from inert substrates (cortisone, 11-dehydrocorticosterone) and has been implicated in the pathogenesis of the metabolic syndrome. 11β-HSD1 expression is increased in adipose tissue and decreased in liver in human and rodent obesity. Paradoxically, in chronically high fat-fed mice 11β-HSD1 is down-regulated in adipose tissue. Transcri...

ea0044p94 | Diabetes and Cardiovascular | SFEBES2016

Does precocious dexamethasone treatment advance fetal cardiac maturation?

Batchen Emma , Richardson Rachel , Thomson Adrian , Moran Carmel , Sooy Karen , Homer Natalie , Gray Gillian , Chapman Karen

Synthetic glucocorticoids are administered to pregnant women at risk of pre-term delivery to mature organs and improve neonatal survival. We have shown that glucocorticoid action is essential to mature the fetal heart. Here, we tested the hypotheses that antenatal glucocorticoid exposure, prior to the normal increase in glucocorticoid levels, will advance fetal heart maturation and this will depend on cardiovascular glucocorticoid receptor (GR).Male SMGR...

ea0038fp3 | (1) | SFEBES2015

Maternal genotype is an important determinant of the outcome of antenatal glucocorticoid treatment in GR+/+ and GR+/− foetal mice

Batchen Emma , Richardson Rachel , Thomson Adrian , Moran Carmel , Gray Gillian , Chapman Karen

Glucocorticoids are routinely administered to pregnant women at risk of pre-term delivery to mature foetal organs and improve neonatal survival. Previous work in glucocorticoid receptor (GR)-deficient mice showed that GR activation is essential for maturation of the foetal heart. Here, we tested the hypotheses that i) antenatal glucocorticoid exposure, prior to the normal increase in glucocorticoid levels, will advance foetal heart maturation and ii) this would depend on mater...